Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients

Mise à jour : Il y a 4 ans
Référence : NCT00830102

Femme et Homme

Extrait

The primary purpose was to evaluate the efficacy of SKP FlutiForm HFA MDI compared to placebo or fluticasone and formoterol administered concurrently or alone in asthma patients.


Critère d'inclusion

  • Asthma

Liens